Clinical Research

parexel-opens-its-6th-office-in-china-located-in-shenyang

Parexel opens its 6th office in China

  • China
  • |
  • News

Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development capabilities in the country and throughout the Asia Pacific region. The... Read more

merck-serono-quintiles-sign-clinical-research-deal

Merck Serono, Quintiles sign clinical research deal...


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merck Serono and Quintiles have signed a new, five-year clinical development agreement. This strategic collaboration... Read more

kansas-bioscience-authority-kba-pays-received-usd400-000-to-pra-create-80-new-jobs

US state pays PRA $0.4 mn for creating jobs


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority... Read more

mr-tarun-pandotra-project-manager-pra-india

Mr Tarun Pandotra, PRA India: Drug discovery outsourcing will gain momentum in 2013

  • India
  • |
  • Opinion
  • |
  • By Mr Tarun Pandotra
  • |
  • 0 Comment

The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market will be stimulated... Read more

mr-denzil-benjamin-senior-director-clinical-trial-management-asia-pacific-icon-clinical-research-india

Mr Denzil Benjamin, ICON: New guidelines by India’s CDSCO will re-define the industry in 2013...

  • India
  • |
  • Opinion
  • |
  • By Mr Denzil Benjamin
  • |
  • 0 Comment

Adapting technology and tools to address the issues of increasing research and development (R&D) costs, slow results, lack of funding, regulatory... Read more

dr-anthony-s-rebuck-senior-consultant-head-of-strategic-drug-development-asia-quintiles-singapore

Dr Anthony S Rebuck, Quintiles: Entry of new biosimilars will transform biopharma in 2013

  • Singapore
  • |
  • Opinion
  • |
  • By Dr Anthony S Rebuck
  • |
  • 0 Comment

Big news in 2013 will be the growth of biosimilars in the biologics segment. By the end of the year, biosimilars will account for five percent... Read more

merck-halts-study-of-tredaptive-as-it-did-not-meet-its-primary-endpoint

Merck drops Tredaptive study

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: HPS2-THRIVE (heart protection study 2-treatment of HDL to reduce the incidence of vascular events) study of Tredaptive (extended-release... Read more

hope-for-anxiety-patients-bionomics-licensee-ironwood-begins-phase-i-trial-of-investigational-iw-2143

Bionomics begins phase I trial of anxiety drug

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bionomics has been advised by its licensee, Ironwood Pharmaceuticals, that following the submission of an Investigational New... Read more

Biotech-310x175_copy

ASKLEP joins Medidata partner program

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part... Read more

quintiles-signs-bioanalytical-deal-with-korean-cro

Quintiles signs bioanalytical deal with Korean CRO

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: To enhance its bioanalytical service offerings in Asia, Quintiles has signed an exclusive partnership with BioCore, a leading... Read more

clinuvel-clinical-trial

Clinuvel gets positive results in Scenesse trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its US phase IIa pilot... Read more

Biotech-310x175_copy

WuXi, PRA collaborate to provide services in China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: WuXi PharmaTech, a leading contract research organization with operations in China US, and PRA have signed a joint venture... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X